RDHL

Redhill Biopharma Ltd.

1.32 USD

Last updated Dec 11, 22:27 UTC

Yesterday HIGH

$1.42

Yesterday LOW

$1.21

52w HIGH

$11.5

52w LOW

$0.26

EPS

0.09

PE

14.67

Next Earnings

Dec 22, 2023

Overview News Government Trades

Redhill Biopharma Ltd. stock is up 325.81% since 30 days ago. The next earnings date is Dec 22, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 27.27% of the previous 10 December’s closed higher than November.

RedHill Biopharma Ltd. primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Tel Aviv, Israel

Website

redhillbio.com

Benzinga Insights

Tue Nov 28, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Lisa Levin

Tue Nov 28, 2023

Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors. SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading
Benzinga Insights

Mon Nov 27, 2023

12 Health Care Stocks Moving In Monday's After-Market Session
Lisa Levin

Mon Nov 27, 2023

Crude Oil Falls; RedHill Biopharma Shares Spike Higher

U.S. stocks traded mixed toward the end of trading on Monday. The Dow traded down 0.13% to 35,344.56 while the NASDAQ rose 0.11% to 14,266.69. The S&P 500 also fell, dropping, 0.08% to 4,555.47.
Lisa Levin

Mon Nov 27, 2023

Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.
Benzinga Insights

Mon Nov 27, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Lisa Levin

Mon Nov 27, 2023

Nasdaq Moves Higher; US New Home Sales Fall In October

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite moving higher on Monday. The Dow traded down 0.23% to 35,310.40 while the NASDAQ rose 0.21% to 14,280.12. The S&P 500 also fell, dropping, 0.07% to 4,556.10.
Lisa Levin

Mon Nov 27, 2023

US Stocks Lower; Dow Falls Over 50 Points

U.S. stocks traded lower this morning, with the Dow Jones index falling over 50 points on Monday. Following the market opening Monday, the Dow traded down 0.18% to 35,328.05 while the NASDAQ fell 0.13% to 14,231.78. The S&P 500 also fell, dropping, 0.25% to 4,548.14.
Vandana Singh

Mon Nov 27, 2023

Why Is Gastrointestinal Disease Focused-RedHill Biopharma Stock Higher Over 100% Today?

The FDA has granted five years' market exclusivity for RedHill Biopharma Ltd's (NASDAQ: RDHL) Talicia under the Generating Antibiotic Incentives Now Act Qualified Infectious Disease Product designation, as recommended by the
Benzinga Insights

Mon Nov 27, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session